# Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries

> **NCT06590675** · NA · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 19 (actual)

## Conditions studied

- Multidrug Resistant Bacterial Infection

## Interventions

- **DRUG:** Chlorhexidine Gluconate (CHG)

## Key facts

- **NCT ID:** NCT06590675
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-02-19
- **Primary completion:** 2025-03-19
- **Final completion:** 2025-03-19
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Funding Withdrawn
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06590675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06590675, "Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06590675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*